Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for human liver disease

S E Raper1, J M Wilson

  • 1Institute for Human Gene Therapy, Wistar Institute, University of Pennsylvania School of Medicine, Philadelphia, USA.

Progress in Liver Diseases
|January 1, 1995
PubMed
Summary

Gene therapy holds immense potential but faces significant challenges in vector technology and biological understanding. Future advancements will focus on liver diseases like familial hypercholesterolemia and ornithine transcarbamylase deficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fission yeast myosin-II isoforms assemble into contractile rings at distinct times during mitosis.

Current biology : CB·2001
Same author

Anteroapical stunning and left ventricular outflow tract obstruction.

Mayo Clinic proceedings·2001
Same author

Congenital diaphragmatic hernia: where are we and where do we go from here?

Seminars in perinatology·2001
Same author

Pulmonary morbidity in 100 survivors of congenital diaphragmatic hernia monitored in a multidisciplinary clinic.

Journal of pediatric surgery·2001
Same author

A quantitative nonimmunogenic transgene product for evaluating vectors in nonhuman primates.

Molecular therapy : the journal of the American Society of Gene Therapy·2000
Same author

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Journal of virology·2000

Area of Science:

  • Gene therapy
  • Medical research

Background:

  • Gene therapy is a rapidly evolving field with vast potential across medical disciplines.
  • Current gene transfer technologies in clinical trials have substantial limitations.
  • Fundamental biological knowledge of target organs and disease pathogenesis is crucial for progress.

Purpose of the Study:

  • To evaluate the current state and future directions of gene therapy.
  • To identify near-term therapeutic targets for gene therapy.
  • To discuss challenges and opportunities in developing effective gene therapy vectors.

Main Methods:

  • Review of current gene transfer technologies and clinical trial limitations.
  • Assessment of biological knowledge gaps in gene therapy.
  • Identification of promising liver diseases for gene therapy application.

Main Results:

  • Gene therapy is in its early stages, with vector systems needing discovery.
  • Familial hypercholesterolemia and ornithine transcarbamylase deficiency are identified as near-term targets.
  • Adenoviruses and retroviruses are under consideration for liver disease treatment, despite inflammatory responses.

Conclusions:

  • Continued fundamental research is essential for advancing gene therapy.
  • Overcoming limitations in vector technology and biological understanding is key to effective therapy.
  • The liver is a primary target for near-term gene therapy applications due to vector efficiency.

Related Experiment Videos